Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Ms. Roopa Raman of International Finance Corporation (IFC), would be having a meeting with our General Manger-Finance, Mr. Sachin Salvi and Head-Strategy and Corporate Development, Mr. Vatsal Goyal, at our office by 11.00 A.M. today (Wednesday, 23rd May 2018).... Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Thursday, May 03, 2018 at 3.00 P.M. local time, to discuss the Company's Audited financial results (Stand-alone and Consolidated) for Quarter/ Year ended March 31, 2018. Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO and Mr. Sachin Salvi, GM-Finance and Mr. Vatsal... Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Sandip Patodia, Equity Analyst of Fundsmith LLP, would be having a meeting with our Chairman & Managing Director, Dr. A. Velumani, General Manager- Finance, Mr. Sachin Salvi and Head- Strategy and Development, Mr. Vatsal Goyal, at our office by 10.30 A.M. on Wednesday, 06th June 2018. He will also visit our Lab in the morning before the meeting.... Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Vinod Jayaram, Senior Investment Analyst, of Elara Capital, would be having a meeting with our General Manager- Finance, Mr. Sachin Salvi and Head- Strategy and Development, Mr. Vatsal Goyal, at our office by 11.00 A.M. on Thursday, 10th May 2018.... Announcement under Regulation 30 (LODR)-Investor Presentation
We are forwarding copy of Presentation on Annual Results of our company for the year ended 31-03-2018. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised. Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are forwarding copy of Media Release on Annual Results of our company for the year ended 31-03-2018. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised. Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a conference call for the Indian and overseas analysts is arranged by our management to discuss the Company's financial results for Quarter / Year ended March 31, 2018, on Thursday, May 03, 2018 at 3.00 P.M. local time. Our Chairman & Managing Director, Dr. A. Velumani, Executive Director & CFO, Mr. A. Sundararaju, General... Board recommends Final Dividend
Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 28, 2018, inter alia, have recommended the payment of final dividend of Rs. 5/- (Rupees five only) per equity share of the face value of Rs. 10 each. Board recommends Final Dividend
Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 28, 2018, inter alia, have recommended the payment of final dividend of Rs. 5/- (Rupees five only) per equity share of the face value of Rs. 10 each.